Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:43 pm Purchase | 2024-12-31 | 13G | Sunshine Biopharma, Inc. SBFM | L1 Capital Global Opportunities Master Fund, Ltd. | 142,244 4.990% | 139,601 (+5282.21%) | Filing History |
| 2024-11-14 4:28 pm Unchanged | 2024-09-30 | 13G | Sunshine Biopharma, Inc. SBFM | Armistice Capital, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-23 4:03 pm Purchase | 2024-02-13 | 13G | Sunshine Biopharma, Inc. SBFM | L1 Capital Global Opportunities Master Fund, Ltd. | 2,643 5.300% | 2,643 (New Position) | Filing History |
| 2024-02-21 4:28 pm Purchase | 2024-02-13 | 13G | Sunshine Biopharma, Inc. SBFM | Altium Capital Management LLC | 4,500 9.990% | 4,500 (New Position) | Filing History |
| 2024-02-14 3:53 pm Purchase | 2023-12-31 | 13G | Sunshine Biopharma, Inc. SBFM | Armistice Capital, LLC | 1,065 7.600% | 1,065 (New Position) | Filing History |
| 2022-11-02 11:13 am Purchase | 2022-10-20 | 13G | Sunshine Biopharma, Inc. SBFM | Chamoun Malek | 1,850 16.400% | 1,850 (New Position) | Filing History |
| 2021-07-29 4:45 pm Purchase | 2021-07-20 | 13G | Sunshine Biopharma, Inc. SBFM | Beathard Robert King 3rd | 98 8.070% | 98 (New Position) | Filing History |